Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Intuitive Surgical
ISRG
|
+$875M |
| 3 |
Amazon
AMZN
|
+$816M |
| 4 |
Intercontinental Exchange
ICE
|
+$721M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$661M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.3B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$971M |
| 3 |
Apple
AAPL
|
+$593M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$419M |
| 5 |
Shopify
SHOP
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.02% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.26% |
| 4 | Communication Services | 8.33% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
RE/MAX Holdings
RMAX
$203M
| $1.83M | ﹤0.01% |
56,047
-2,024
| -3% | -$68K |
|
3627
Modine Manufacturing
MOD
$10.4B
| $1.83M | ﹤0.01% |
293,326
+76,950
| +36% | +$466K |
|
|
EVFM
3628
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.83M | ﹤0.01% |
51,733
-151,909
| -75% | -$6.6M |
|
3629
iShares Core 5-10 Year USD Bond ETF
IMTB
$276M
| $1.83M | ﹤0.01% |
34,937
-18,924
| -35% | -$993K |
|
|
PNF
3630
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $1.83M | ﹤0.01% |
159,092
+52,395
| +49% | +$617K |
|
3631
Werner Enterprises
WERN
$2.24B
| $1.83M | ﹤0.01% |
43,504
-182,606
| -81% | -$8.09M |
|
|
CARM
3632
DELISTED
Carisma Therapeutics
CARM
| $1.83M | ﹤0.01% |
65,188
+64,822
| +17,711% | +$1.3M |
|
3633
Photronics
PLAB
$1.87B
| $1.82M | ﹤0.01% |
183,036
+3,622
| +2% | +$39.1K |
|
|
GHG
3634
GreenTree Hospitality
GHG
$113M
| $1.82M | ﹤0.01% |
134,067
+61,489
| +85% | +$809K |
|
|
BCLI
3635
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.82M | ﹤0.01% |
7,177
+1,561
| +28% | +$320K |
|
3636
BellRing Brands
BRBR
$1.44B
| $1.82M | ﹤0.01% |
87,630
-328,668
| -79% | -$6.47M |
|
3637
Mercury Insurance
MCY
$5.98B
| $1.82M | ﹤0.01% |
43,893
-11,292
| -20% | -$485K |
|
3638
Amphastar Pharmaceuticals
AMPH
$882M
| $1.82M | ﹤0.01% |
96,838
-25,443
| -21% | -$512K |
|
3639
Revolution Medicines
RVMD
$41.8B
| $1.82M | ﹤0.01% |
52,184
+22,431
| +75% | +$621K |
|
3640
Theravance Biopharma
TBPH
$876M
| $1.81M | ﹤0.01% |
122,443
-280,092
| -70% | -$5.25M |
|
3641
Marcus Corp
MCS
$959M
| $1.8M | ﹤0.01% |
233,652
+141,917
| +155% | +$1.91M |
|
3642
Archrock
AROC
$5.9B
| $1.8M | ﹤0.01% |
334,988
-31,105
| -8% | -$203K |
|
|
ACV
3643
Virtus Diversified Income & Convertible Fund
ACV
$282M
| $1.8M | ﹤0.01% |
70,974
+13,456
| +23% | +$343K |
|
3644
Fortuna Silver Mines
FSM
$2.93B
| $1.8M | ﹤0.01% |
282,483
+180,762
| +178% | +$1.16M |
|
|
EMFM
3645
DELISTED
Global X MSCI Next Emerging & Frontier ETF
EMFM
| $1.79M | ﹤0.01% |
108,164
+1,708
| +2% | +$28.5K |
|
3646
Minerals Technologies
MTX
$2.41B
| $1.79M | ﹤0.01% |
35,100
-7,439
| -17% | -$368K |
|
3647
Cohu
COHU
$2.38B
| $1.79M | ﹤0.01% |
104,280
-11,375
| -10% | -$199K |
|
|
LBAI
3648
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.79M | ﹤0.01% |
179,963
+130,390
| +263% | +$1.38M |
|
|
DVAX
3649
DELISTED
Dynavax Technologies
DVAX
| $1.79M | ﹤0.01% |
413,805
-153,879
| -27% | -$1.1M |
|
3650
Manchester United
MANU
$3.88B
| $1.79M | ﹤0.01% |
122,900
-30,222
| -20% | -$461K |
|
Similar funds
Morgan Stanley's Q3 2020 Portfolio in Review
As of Q3 2020, Morgan Stanley held 7,017 positions worth $517B, up 14% from $452B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley deployed $20.1B of net new capital in Q3 2020, opening 295 new positions and adding to 2,843 existing holdings. Its largest new stake was Snowflake: 1,409,359 shares worth $354M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.
- Morgan Stanley's largest Q3 2020 buy was Snowflake: 1,409,359 shares worth $354M.
- Morgan Stanley added most to Invesco QQQ Trust in Q3 2020, an estimated $1.09B increase.
- Morgan Stanley's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
- Morgan Stanley fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $90.7M.
- Morgan Stanley's ten largest holdings make up 17% of its $517B portfolio in Q3 2020.
- Morgan Stanley opened 295 new positions and closed 175 in Q3 2020.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $517B.
Based on Morgan Stanley's 13F filing for Q3 2020, filed 13 Nov 2020.